{"name":"AngioDynamics","slug":"angiodynamics","ticker":"ANGO","exchange":"NASDAQ","domain":"angiodynamics.com","description":"AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter,","hq":"Latham, NY","founded":0,"employees":"675","ceo":"Jim Clemmer","sector":"Vascular & Interventional Oncology Devices","stockPrice":11.16,"stockChange":0.32,"stockChangePercent":2.95,"marketCap":"$461M","metrics":{"revenue":313724992,"revenueGrowth":8.9,"grossMargin":54.3,"rdSpend":26222000,"netIncome":-33993000,"cash":37810000,"dividendYield":0,"peRatio":-50.7,"fiscalYear":"FY2021"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"AngioDynamics Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"AngioDynamics reported revenue of $83.1 million for the fourth quarter of 2023, a decrease of 4.3% compared to the same period in 2022. The company also reported a net loss of $1.4 million for the quarter.","drugName":"","sentiment":"neutral"},{"date":"2023-09-14","type":"deal","headline":"AngioDynamics Announces Agreement to Acquire Navilyst Medical","summary":"AngioDynamics has entered into an agreement to acquire Navilyst Medical, a provider of vascular access products, for $220 million.","drugName":"","sentiment":"positive"},{"date":"2023-06-15","type":"regulatory","headline":"AngioDynamics Receives FDA Clearance for VenaSeal Closure System","summary":"AngioDynamics has received FDA clearance for its VenaSeal Closure System, a non-occlusive venous closure system.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxPTGk1S1B0NDF4VU00WXZ3UWoxRWVDRUVVV1YyQVhNRG4tX0dWTy1JRTNxMHJkSVZnZWlodGRaZHJnbVkyUUp2NnJnVHZQR3pNalhuTVJnWTNmU3ZYQTBIb3dhM1lrQlowcDl0WE0zSWZ4YlhLWENWajlDWldFenRMTkF1YWhOWDlkOV9PYXJPS2hZME9SUEd4bUg5SGFjWGVkUUg0NklPOWZVT2xJZDBVX0NPTDlHTllHODUxZXI1dkRyTE5DS1NTREFQcnFmYVVmckppUG5tZW5IcjQ?oc=5","date":"2026-04-07","type":"pipeline","source":"The Globe and Mail","summary":"Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail","headline":"Wall Street Analysts Are Bullish on Top Healthcare Picks","sentiment":"neutral"},{"date":"2026-04-02","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2026-04-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOMEx6TmY1bjRkLUdGdHNsQXFnandlTkpxYzlUYUlaZVY2YXM3SkFNaUtvV0oxUjA1QXFXZUhLek9sQjlYOGV6Z3JUMmNhRW5zTDZMbEV4M05sanRTdFNWWG9sQngxZUoxbzczWEQwZ3dtUVhJc01qVmE4clNGMGN3SkV3Tnh4MkhkVW81dlozbzk1TlRQLWRGc292WFJFR1FKOEt4MjV2azREUWFrUWpqVUlhMHE?oc=5","date":"2026-02-13","type":"earnings","source":"TradingView","summary":"Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y - TradingView","headline":"Waters Q4 Earnings Surpass Estimates, Revenues Increase Y/Y","sentiment":"neutral"},{"date":"2026-02-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-01-14","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOU1ZQWkJ4djdhcUMxMm9sZHJrRmVEWjZ0U3RMbkVFQXhBbjcwLTBLTVVOaWJtT0g1VUJ5MWdDSGIyeUVscmZlS3pCOXBiWDNfSVVFN2plbEt5ZklMS0NKbWxiY1JTMGg3eFczeUNoaHNwd05DOEotVlpsZS1TOTFzY2Qtd19SekhMTTYw?oc=5","date":"2026-01-06","type":"pipeline","source":"The Motley Fool","summary":"Why AngioDynamics Stock Is Sinking Today - The Motley Fool","headline":"Why AngioDynamics Stock Is Sinking Today","sentiment":"neutral"},{"date":"2026-01-06","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2026-01-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOaHRqOHpUR0pxUGdBWkNheHFyRGY2dkhGWlAzZlBlQktQSFlwMFZjem5IWklHLUFhaFRTN0ljbi14d2dJby0zVXNZaXZaX1pETHZ5djE1U0NfMERNQ1BYUi1XR3huV0tqN2JDSkhCRFVxanE0TUNKckVfWkMtUEloN1pjU3B1d2JVUW9EOTJn?oc=5","date":"2025-12-29","type":"regulatory","source":"Seeking Alpha","summary":"AngioDynamics: Growth Remains Under The Radar (NASDAQ:ANGO) - Seeking Alpha","headline":"AngioDynamics: Growth Remains Under The Radar (NASDAQ:ANGO)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxONkkwR0RZQU1mUWM3WmlPSmVmUnpsbnF0dDZzclNLTmxyMUItbzNZaklTWFRybUZ5bjNRbUF2bFp0MVlxeFkwX0o4bWNYbXRHTzEwQndQZ25qMm1iUE1TMkctT2pxVDFnNkRTQ0ZDcmlnQUc0ZDBwRTFuaEt2c0VLeURwbnJyUXFtXzBDWGN1bjY4a245UXZfOWhpRFhWQTc1aXNjd3pIR2FwbFM3Z2dOcjk5M3NCREdE?oc=5","date":"2025-12-23","type":"earnings","source":"Stock Titan","summary":"Medical tech company sets Jan. 6 call to share latest quarter - Stock Titan","headline":"Medical tech company sets Jan. 6 call to share latest quarter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPTE5kV3pmRVVkZ2czUG9CTUlPMm10bnhiU2FBMXg4VU10Yl93QU1XczdIWW5jb0Jmb0ViajhaVHN4c25KSFVZeXBDZkdFN0w5UDNBY19hWkhyRnZBZ21HcmhrbXFjemhnc01OVXpHRWdSdUw2LU9MTkZjLThMMFlXS292bV9zTlJvekU5aDR1dllWekUtLV9IQUR6aXNGZmF3MFRBbkhJdTQ3M05iWm0td0k3c0x6Uk10aGFhM1hR?oc=5","date":"2025-12-22","type":"pipeline","source":"Stock Titan","summary":"New York medtech firm to present at J.P. Morgan healthcare conference - Stock Titan","headline":"New York medtech firm to present at J.P. Morgan healthcare conference","sentiment":"neutral"},{"date":"2025-11-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOZjNRQmI1U1VqZHNTYlRVMjNtdXRWdTBxbm00bzR3cExGWGpLUG9USnp0YnNDRTc1WWljbnV4VmtpcE01cGtGM1NLbmF1bHBxS0NYVUVCSWwwNU9JTXpyNU1KTzV1NXREdGRFOWtuUV9CVWxkbFYydG1KajhSc3VHVlVpbDVrT2VIWndBWGQ2OFB3T09HanpRTDlrU3RSNXJXMnIzRzhMVDE?oc=5","date":"2025-10-02","type":"pipeline","source":"Seeking Alpha","summary":"AngioDynamics: Discounted Sales Multiple With Real Growth Engines (NASDAQ:ANGO) - Seeking Alpha","headline":"AngioDynamics: Discounted Sales Multiple With Real Growth Engines (NASDAQ:ANGO)","sentiment":"neutral"},{"date":"2025-10-02","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Becton Dickinson and Company","Boston Scientific Corporation","Cook Medical"],"therapeuticFocus":["Vascular Access","Interventional Oncology"],"financials":{"source":"sec_edgar+yahoo","revenue":291010000,"revenuePeriod":"2021-05-31","revenueHistory":[{"value":291010000,"period":"2021-05-31"},{"value":264157000,"period":"2020-05-31"},{"value":264157000,"period":"2020-05-31"},{"value":58332000,"period":"2020-05-31"},{"value":69780000,"period":"2020-02-29"}],"grossProfit":157705000,"grossProfitHistory":[{"period":"2025-05-31","value":157705000},{"period":"2024-05-31","value":154698000},{"period":"2023-05-31","value":174246000},{"period":"2022-05-31","value":165732000}],"rdSpend":26222000,"rdSpendHistory":[{"period":"2025-05-31","value":26222000},{"period":"2024-05-31","value":31512000},{"period":"2023-05-31","value":29883000},{"period":"2022-05-31","value":30739000}],"sgaSpend":145227000,"operatingIncome":-24062000,"operatingIncomeHistory":[{"period":"2025-05-31","value":-24062000},{"period":"2024-05-31","value":-33844000},{"period":"2023-05-31","value":-18679000},{"period":"2022-05-31","value":-18217000}],"netIncome":-33993000,"netIncomeHistory":[{"period":"2025-05-31","value":-33993000},{"period":"2024-05-31","value":-184349000},{"period":"2023-05-31","value":-52442000},{"period":"2022-05-31","value":-26547000}],"eps":-0.83,"epsHistory":[{"period":"2025-05-31","value":-0.83},{"period":"2024-05-31","value":-4.59},{"period":"2023-05-31","value":-1.33},{"period":"2022-05-31","value":-0.68}],"cash":55893000,"cashHistory":[{"period":"2025-05-31","value":55893000},{"period":"2024-05-31","value":76056000},{"period":"2023-05-31","value":44620000},{"period":"2022-05-31","value":28825000}],"totalAssets":280144000,"totalLiabilities":97174000,"totalDebt":4728000,"equity":182970000,"operatingCashflow":-10128000,"operatingCashflowHistory":[{"period":"2025-05-31","value":-10128000},{"period":"2024-05-31","value":-28158000},{"period":"2023-05-31","value":78000},{"period":"2022-05-31","value":-7194000}],"capex":-4464000,"capexHistory":[{"period":"2025-05-31","value":-4464000},{"period":"2024-05-31","value":-5768000},{"period":"2023-05-31","value":-4352000},{"period":"2022-05-31","value":-4297000}],"freeCashflow":-14592000,"dividendsPaid":null,"buybacks":-1670000,"employees":675,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":38156000,"ebit":-6429000,"ebitda":-838000,"period":"2026-02-28","revenue":78423000,"epsBasic":-0.19,"netIncome":-8084000,"rdExpense":7084000,"epsDiluted":-0.19,"grossProfit":41479000,"operatingIncome":-6429000},{"sga":36862000,"ebit":-2490000,"ebitda":3257000,"period":"2025-11-30","revenue":79433000,"epsBasic":-0.15,"netIncome":-6350000,"rdExpense":7768000,"epsDiluted":-0.15,"grossProfit":44783000,"operatingIncome":-2490000},{"sga":40685000,"ebit":-7898000,"ebitda":-1878000,"period":"2025-08-31","revenue":75711000,"epsBasic":-0.26,"netIncome":-10903000,"rdExpense":6417000,"epsDiluted":-0.26,"grossProfit":41857000,"operatingIncome":-7898000},{"sga":36673000,"ebit":-3633000,"ebitda":2200000,"period":"2025-05-31","revenue":80158000,"epsBasic":-0.15,"netIncome":-6050000,"rdExpense":6590000,"epsDiluted":null,"grossProfit":42218000,"operatingIncome":-3633000},{"sga":35994000,"ebit":-6648000,"ebitda":-329000,"period":"2025-02-28","revenue":72004000,"epsBasic":-0.11,"netIncome":-4407000,"rdExpense":6913000,"epsDiluted":-0.11,"grossProfit":38857000,"operatingIncome":-6648000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-11-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":-0.26,"grossProfit":null,"operatingIncome":null},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-08-31","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":11.16,"previousClose":10.84,"fiftyTwoWeekHigh":13.99,"fiftyTwoWeekLow":8.36,"fiftyTwoWeekRange":"8.36 - 13.99","fiftyDayAverage":10.77,"twoHundredDayAverage":11.08,"beta":0.37,"enterpriseValue":425417920,"forwardPE":-50.7,"priceToBook":2.68,"priceToSales":1.47,"enterpriseToRevenue":1.36,"enterpriseToEbitda":-645.55,"pegRatio":0,"ebitda":-659000,"ebitdaMargin":-0.2,"freeCashflow":13942250,"operatingCashflow":4448000,"totalDebt":11394000,"debtToEquity":6.6,"currentRatio":2.35,"returnOnAssets":-4.7,"returnOnEquity":-17.5,"analystRating":"","recommendationKey":"none","numberOfAnalysts":4,"targetMeanPrice":18,"targetHighPrice":24,"targetLowPrice":16,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":12.3,"institutionHeldPercent":92.6,"sharesOutstanding":41318915,"floatShares":34967111,"sharesShort":2070280,"shortRatio":4.14,"shortPercentOfFloat":5,"epsTrailing":-0.76,"epsForward":-0.22,"revenuePerShare":7.59,"bookValue":4.16,"officers":[{"age":61,"name":"Mr. James C. Clemmer","title":"CEO, President & Director"},{"age":51,"name":"Mr. Stephen A. Trowbridge","title":"Executive VP & CFO"},{"age":55,"name":"Mr. Lawrence T. Weiss","title":"Senior VP, Chief Legal Officer & Corporate Secretary"},{"age":56,"name":"Mr. Warren G. Nighan","title":"Senior Vice President of Regulatory Affairs, Quality & Global Supply Chain"},{"age":56,"name":"Ms. Laura  Piccinini","title":"Senior VP and GM of Cardiovascular & International"},{"age":null,"name":"Mr. Saleem M. Cheeks","title":"Vice President of Communications"},{"age":61,"name":"Mr. Benjamin H. Davis","title":"Senior Vice President of Business Development & Strategy"},{"age":58,"name":"Ms. Marna I. Bronfen-Moore","title":"Senior Vice President of Human Resources"}],"industry":"Medical Instruments & Supplies","irWebsite":"","website":"https://www.angiodynamics.com","phone":"518 795 1400"}}